Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations
R He, S Zhao, M Cui, Y Chen, J Ma, J Li… - Frontiers in …, 2023 - frontiersin.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disease typically involving the
gastrointestinal tract but not limited to it. IBD can be subdivided into Crohn's disease (CD) …
gastrointestinal tract but not limited to it. IBD can be subdivided into Crohn's disease (CD) …
Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
A Oganesyan, A Gregory, F Malard… - Frontiers in …, 2022 - frontiersin.org
Monoclonal gammopathy of clinical significance (MGCS) represents a new clinical entity
referring to a myriad of pathological conditions associated with the monoclonal gammopathy …
referring to a myriad of pathological conditions associated with the monoclonal gammopathy …
Pyoderma gangrenosum and interleukin inhibitors: a semi-systematic review
H Ben Abdallah, K Fogh, C Vestergaard, R Bech - Dermatology, 2022 - karger.com
Background: Pyoderma gangrenosum (PG) is a rare ulcerating skin disease associated with
multiple comorbidities and increased mortality. In recent decades, newer biologics such as …
multiple comorbidities and increased mortality. In recent decades, newer biologics such as …
Neutrophilic and eosinophilic dermatoses associated with hematological Malignancy
CA Maronese, F Derlino, C Moltrasio… - Frontiers in …, 2024 - frontiersin.org
Cutaneous manifestations of hematologic malignancy represent both a clinical challenge for
the treating physician and a pathophysiological model for advancing the knowledge on …
the treating physician and a pathophysiological model for advancing the knowledge on …
Clinical guidance of pyoderma gangrenosum 2022
T Yamamoto, K Yamasaki, K Yamanaka… - The Journal of …, 2023 - Wiley Online Library
Pyoderma gangrenosum (PG) is a rare, neutrophilic skin disease. For the purpose of
accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for …
accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for …
[HTML][HTML] Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes
The epidermis is the outermost layer of skin. Here, we used targeted lipid profiling to
characterize the biogeographic alterations of human epidermal lipids across 12 …
characterize the biogeographic alterations of human epidermal lipids across 12 …
Global burden of bacterial skin diseases: a systematic analysis combined with sociodemographic index, 1990–2019
Y Xue, J Zhou, BN Xu, Y Li, W Bao, XL Cheng… - Frontiers in …, 2022 - frontiersin.org
Background The latest incidence and disability-adjusted life-years (DALYs) of major
bacterial skin diseases (BSD) and their relationship with socioeconomic are not readily …
bacterial skin diseases (BSD) and their relationship with socioeconomic are not readily …
Pyoderma gangrenosum induced by BNT162b2 COVID-19 vaccine in a healthy adult
M Barry, A AlRajhi, K Aljerian - Vaccines, 2022 - mdpi.com
(1) Background: Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis of unknown
etiology. Coronavirus disease 2019 (COVID-19) vaccines can cause a variety of adverse …
etiology. Coronavirus disease 2019 (COVID-19) vaccines can cause a variety of adverse …
Cutaneous manifestations of inflammatory bowel disease: A basic overview
K Pagani, D Lukac, A Bhukhan, JS McGee - American journal of clinical …, 2022 - Springer
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
(GI) tract that is subdivided into Crohn's disease (CD) and ulcerative colitis (UC). CD is …
(GI) tract that is subdivided into Crohn's disease (CD) and ulcerative colitis (UC). CD is …
Use of granulocyte and monocyte adsorption apheresis in dermatology
L Gnesotto, G Mioso, M Alaibac - Experimental and …, 2022 - spandidos-publications.com
Adsorptive granulocyte and monocyte apheresis (GMA) is an extracorporeal treatment that
selectively removes activated myeloid lineage leukocytes from peripheral blood. This …
selectively removes activated myeloid lineage leukocytes from peripheral blood. This …